Cost analysis of plasma-derived factor VIII/von Willebrand factor vs recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United States.
| Image |  |
|---|---|
| Description | scientific article published on 21 April 2018 |
| Author/s |
author: Ellis J Neufeld |
| Publication date | June 6, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |